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Mechanisms underlying alternative modes of symmetric versus asymmetric stem cell fates are not well
understood. In this issue of Cell Stem Cell, Bu et al. (2013) find that miR-34a acts as a toggle switch for Notch
signaling that dictates binary symmetric and asymmetric fates in colon cancer stem cells.Asymmetric cell division produces
daughter cells with distinct fates and
demonstrates a capacity for rapid spatial
and temporal generation of phenotypic
variation (Neumu¨ller and Knoblich, 2009).
The cellular machinery involved in deliv-
ering these outcomes and their impact
on stem cell maintenance and differentia-
tion has garnered much interest, but
whether these mechanisms also affect
fate choices in cancer stem cells has
been less well-studied. In this issue of
Cell Stem Cell, Bu et al. (2013) identify a
role for the Notch-targeting microRNA
miR-34a in asymmetric division of colon
cancer stem cells (CCSCs).
miR-34a is a well-characterized micro-
RNA that has been described as a tumor
suppressor gene for many cancer types.
Its widespread downregulation in can-
cers is well documented and has been
attributed to locus deletion or epigenetic
silencing (Vogt et al., 2011). Likewise, in
various contexts, overexpression of miR-
34a can induce apoptosis, senescence,differentiation, cell cycle arrest, and
growth suppression in both in vitro and
in vivo assays. One mechanism by
which miR-34a promotes differentiation
is inhibition of Notch signaling (Li et al.,
2009). Notch signaling is frequently acti-
vated in colorectal cancers (CRCs) and
is dysregulated directly by both epige-
netic and genetic changes and indirectly
by synergistic interactions with the Wnt
pathway, which is also commonly acti-
vated in CRC. In addition, the Notch
pathway has been previously identified
to contribute to asymmetric cell division
in stem cells. These well-characterized
roles for Notch in directing lineage
choice, asymmetric cell division, and
colon cancer prompted Shen and
colleagues to investigate the role of its
upstream regulator, miR-34a, in asym-
metric fate choice in CCSCs.
Using a panel of markers, the authors
isolate a CCSC fraction and confirm its
capacity to propagate the cancers in
tumor xenograft assays. ImportantlyCCSCs are defined by low miR-34a
levels, and overexpression of the micro-
RNA inhibited tumor growth. To investi-
gate modes of cell division in CCSCs,
the authors borrowed from neural biology
a ‘‘paired cell’’ assay, which allows the
fate of single cells to be analyzed using
combinations of differentiation and stem
cell markers on the subsequent pairs that
arise after cell division. Bu et al. identified
asymmetric fates in around 20%–30% of
naive CCSCs. The majority of the other
cell pairs demonstrated symmetric fates
into either CCSCs or non-CCSCs. Experi-
mental elevation or reduction in the levels
of miR-34a further promoted the co-
occurrence of non-CCSCandCCSCsym-
metric fates, respectively. Strikingly, both
manipulations reduce the frequency of
asymmetric fates. In suchpairs, daughters
expressing the stem markers are more
likely to reenter the cell cycle, suggesting
one mechanism by which miR-34a may
be exerting its tumor suppressive role
in CRC.ll 12, May 2, 2013 ª2013 Elsevier Inc. 499
Figure 1. ProposedMechanism for Asymmetric and Symmetric Fate
Determination
A threshold for a bimodal, Notch-regulated cell fate switch is set by miR-34a.
Low levels of miR-34a allow high levels of Notch mRNA to accumulate in stem
cells, including CCSCs (Notch ON), due to either locally presented ligand
(green) or, for CCSCs, (epi)genetic alterations. Thus promoting symmetric
fate choices for self-renewal. High levels of miR-34a act as a molecular
sponge for Notch1 mRNA, effectively turning off Notch signaling (Notch
OFF) and promoting symmetric fates for differentiation. Intermediate miR-
34a levels create a narrow window or ‘‘sweet spot’’ at the threshold whereby
asymmetric fates are promoted.
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gated how these findings
could be linked to the Notch
pathway. They confirmed
that both symmetric and
asymmetric pairs of CCSCs
displayed active levels of
Notch signaling above an
arbitrarily defined threshold.
Further, the overexpression
or knockdown of miR-34a
generated Notch negative or
positive pairs, respectively,
indicating that miR-34a pro-
motes differentiation of
CCSCs via inhibition of Notch
signaling. In this context,
miR-34a appeared to control
fate choice between stem
cell maintenance and differ-
entiation through regulation
of a bimodal switch control-
ling the cell’s perception of
the Notch signal.Mechanistically the authors explain this
observed bimodal distribution in the levels
of Notch among CCSCs by examining the
dynamics of miR-34a and Notch seques-
tration. CCSCs containing Notch reporter
constructs exhibited bimodal distribu-
tions when they contained miR-34a bind-
ing sites but not when these sites were
mutated. Dose-dependent transcriptional
induction of the Notch reporter demon-
strated that miR-34a sequesters available
Notch mRNA until it passes the point of
saturation. They further showed that
Numb, which is a well known posttransla-
tional regulator of Notch, was not respon-
sible for this phenotype.
Effectively then, miR-34a is facilitating
binary fate choice due to a unique stoi-
chometry. The reduction in asymmetric
fates in the daughters of a single division
with experimental elevation or reduction
in miR-34a abundance indicates a ‘‘sweet
spot’’ for asymmetric fate choice. Within
this narrow optimal region, stochastic var-
iations in the partitioning of miR-34a into
daughter cells likely explain the observed
effects.
There are many hundreds of different
gene transcripts that are regulated by
miR-34a (Lal et al., 2011). With this level
of pleiotropism it seems probable that the
many other processes it regulates may in-
fluence some or all of the observations
made. For example, reduced availability
of miR-34a associates with a proprolifera-500 Cell Stem Cell 12, May 2, 2013 ª2013 Eltive phenotype, and rapid cell cycling itself
may limit accumulation of the microRNA,
thus causing a feedforward loop. The fre-
quency of divisions resulting in asym-
metric fates may also be influenced by
how culture alters cell cycling times.
Across a small number of cancers, the
authors find that asymmetric fate choice
correlates with less advanced, more
differentiated tumors and not with more
advanced cancers, suggesting that fate
asymmetry may be a retained feature of
stem cells in homeostasis. Where and
under what circumstances might asym-
metric fate choice be exploited? Inter-
pretation of the growth dynamics of
stem-cell-derived clones has previously
demonstrated that symmetric fate choice
is a common feature of intestinal stem cell
self-renewal (Lopez-Garcia et al., 2010).
However, asymmetric fate choices could
be interspersed with symmetric ones
and still be compatible with these models
(e.g., if smaller numbers of stem cells per
crypt are assumed; Snippert et al., 2010)).
Alternatively, asymmetric fate choice
might be a feature of a specific subpopu-
lation of intestinal progenitors. Within the
crypt base, expression of the Notch
ligands Dll1 and Dll4 in differentiated Pan-
eth cells maintains high levels of Notch
activity in the juxtaposed stem cells (Pel-
legrinet et al., 2011). In this situation
miR-34a would be unlikely to reach a
threshold that would allow acquisition ofsevier Inc.asymmetric fates. However,
outside of the crypt base and
in the absence of presented
ligand, Notch levels would be
reduced. In this case, division
fates may well be determined
by miR-34a. Do these supra-
basal positions include stem
cells or are they exclusively
transit amplifying cells?
Currently it is not possible to
be sure (Figure 1). Certainly
cells in these positions may
share overlapping expression
of stem cell markers associ-
ated with the basal interca-
lated cells (Lgr5) and those in
the supra-Paneth cell posi-
tions (Hopx, mTERT) (Itzkovitz
et al., 2012). The dynamics of
the interchange between
these two populations,
although much studied, is not
yet fully resolved.More specifically, miR-34a may act on
cells leaving the crypt base to promote
differentiation along secretory as op-
posed to absorptive routes. High levels
of Notch activation favor expression of
Hes1. Hes1 acts to suppress the basic
helix-loop-helix transcription factor atonal
homolog 1 (Atoh1), which is an absolute
requirement for secretory differentiation.
As levels of active Notch decrease,
increased expression of Atoh1 is favored,
but Atoh1 is frequently silenced in CRCs
(Bossuyt et al., 2009). Thus asymmetric
postmitotic fates in cancer stem cells
may reflect abortive attempts to differen-
tiate along secretory lineages.
Not addressed by Bu et al., and of
importance for the future, is thedetermina-
tion of whether the long-term fate of cells
identified as stem cells differs depending
on whether they are the product of a sym-
metrical or asymmetrical outcome. The
latter are conceivably compromised in
their clonogenic potential, reinforcing the
notion that restoration ofmiR-34a function
may act to limit Notch pathway activation
and serve as therapy to promote
differentiation.REFERENCES
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The evolutionary and lineage relationships between various stromal cell types that support the immune
system are not well understood. Recently, in Immunity, Castagnaro et al. (2013) identifiedmultipotentmesen-
chymal precursors that specifically give rise to stromal cell types in the spleen, but not other lymphoid tissue,
and support injury-induced regeneration.Multicellular organisms are constantly
confronted with parasites and have there-
fore evolved complex immune systems to
cope with this threat. In mammals, the
spleen, lymph nodes, and gut-associated
lymphoid structures play a central role in
the struggle against infections by facili-
tating efficient immune responses (Muel-
ler and Germain, 2009). Lymphoid tissues
possess a unique cellular composition of
immobile stromal cells and highly motile
hematopoietic cells such as lymphocytes
and dendritic cells; precisely regulated
mechanisms ensure that all cells receive
and respond to various types of signals
regulating their differentiation, interaction,
activation, and survival in steady-state
and inflammatory conditions. Tradition-
ally, hematopoietic cells have attracted
the most attention. However, the stromal
compartment also assumes an important
role in maintaining spleen populations
during homeostasis and in response to
injury, thus prompting Castagnaro and
colleagues (Castagnaro et al., 2013) to
examine the developmental origin andregenerative capacity of stromal cells in
the spleen.
The spleen belongs to the diverse
group of so-called secondary lymphoid
organs whose chief role is the regulation
of immune responses. (By contrast, pri-
mary lymphoid organs—bone marrow
and thymus—fulfill the task of supporting
the generation of the many different kinds
of immune effector cells.) Like other sec-
ondary lymphoid organs, the mature
spleen contains several types of stromal
cells (Figure 1). Previous studies had
failed to provide conclusive evidence
regarding the possible developmental
relationship of these cell types; it was
also unknown whether these different
stromal components shared a common
embryological origin or whether they
were capable of regenerating the stroma
after injury.
In order to examine these questions,
Castagnaro et al. turned to previous
embryological studies indicating that the
mesenchymal primordium of the spleen
(Landsman et al., 2011) expresses thetranscription factor gene Isl1 (Ahlgren
et al., 1997). Several other transcription
factor genes, including Nkx2.5, are also
expressed in the anlage of the spleen and
are important for its proper development
(Brendolan et al., 2007; Koss et al., 2012).
Based on these observations, Castag-
naro et al. carried out two parallel genetic
lineage tracing experiments using the
Cre/loxP system to indelibly mark cells
possessing a history of transcription fac-
tor gene expression. They made the
surprising observation that all types of
stromal cells in the spleen, with the
exception of endothelial cells, are de-
scendants of mesenchymal precursors
that at some stage had expressed either
Nkx2.5 or Isl1. Because Nkx2.5 and Isl1
proteins are coexpressed in mesen-
chymal cells at early stages of develop-
ment, the authors suggest that the com-
mon precursor of splenic stroma is
positive for both Nkx2.5 and Isl1 expres-
sion. At least four morphologically and
functionally distinguishable cell types
were derived from themultipotent stromalll 12, May 2, 2013 ª2013 Elsevier Inc. 501
